Citius Pharmaceuticals, Inc. - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2017-09-15-06:00

Reporting Person: Kane William (N/A)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-15-06:00	Options to Purchase Common Stock	$3.45	A	10000	Acquired	2027-09-13-06:00	Common Stock (10000)	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$0.015	2024-03-28-06:00	Common Stock (12071)	12071	Direct
Options to Purchase Common Stock	$12.00	2026-06-23-06:00	Common Stock (13334)	13334	Direct

F1: The options vest in full on the first anniversary of the vesting commencement date, September 13, 2018.

F2: The option vested in 1/3 increments over a three year period with the first installment vesting on March 28, 2015.

F3: The options vested in full on the first anniversary of the date of grant.